Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
KLRF2 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily F member 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of KLRF2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
KLRF1 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily F member 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of KLRF1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ILKAP Biologics Sequence Review Report 2026: Integrin-linked kinase-associated serine/threonine phosphatase 2C Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of ILKAP protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
ILF2 Biologics Sequence Review Report 2026: Interleukin enhancer-binding factor 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of ILF2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL37 Biologics Sequence Review Report 2026: Interleukin-37 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL37 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL34 Biologics Sequence Review Report 2026: Interleukin-34 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL34 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL27 Biologics Sequence Review Report 2026: Interleukin-27 subunit alpha Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
IL26 Biologics Sequence Review Report 2026: Interleukin-26 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL25 Biologics Sequence Review Report 2026: Interleukin-25 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL24 Biologics Sequence Review Report 2026: Interleukin-24 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL24 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL20 Biologics Sequence Review Report 2026: Interleukin-20 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL1F10 Biologics Sequence Review Report 2026: Interleukin-1 family member 10 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL1F10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.